Table 2. Screening test positivity for VIA, DC, Xpert HPV, and OncoE6 by antiretroviral status.

	Total	On antiretroviral therapy	Not on antiretroviral therapy
VIA (n=199)
Positive	29 (15%)	24 (14%)	5 (25%)
DC (n=200)
Positive	39 (20%)	33 (18%)	6 (30%)
Xpert HPV (n=199)
Any hrHPV positive	94 (47%)	82 (46%)	12 (60%)
HPV16 positive	29 (15%)	26 (15%)	3 (15%)
HPV18/45 positive	22 (11%)	20 (11%)	2 (10%)
HPV31/33/35/52/58 positive	64 (32%)	54 (30%)	10 (50%)
HPV51/59 positive	14 (7%)	13 (7%)	1 (5%)
HPV39/68/56/66 positive	18 (9%)	15 (8%)	3 (15%)
OncoE6 (n=200)
Any hrHPV positive	11 (6%)	11 (6%)	0
HPV16 positive	9 (5%)	9 (5%)	0
HPV18 positive	3 (2%)	3 (2%)	0

VIA: visual inspection with acetic acid; DC: digital cervicography;

^*p<0.05;

^**p<0.01;

^***p<0.001